Journal article
Use and Safety of Immunotherapeutic Management of N-Methyl-d-Aspartate Receptor Antibody Encephalitis
Abstract
Importance: Overall, immunotherapy has been shown to improve outcomes and reduce relapses in individuals with N-methyl-d-aspartate receptor (NMDAR) antibody encephalitis (NMDARE); however, the superiority of specific treatments and combinations remains unclear.
Objective: To map the use and safety of immunotherapies in individuals with NMDARE, identify early predictors of poor functional outcome and relapse, evaluate changes in immunotherapy …
Authors
Nosadini M; Eyre M; Molteni E; Thomas T; Irani SR; Dalmau J; Dale RC; Lim M; Anlar B; Armangue T
Journal
JAMA Neurology, Vol. 78, No. 11, pp. 1333–1344
Publisher
American Medical Association (AMA)
Publication Date
November 1, 2021
DOI
10.1001/jamaneurol.2021.3188
ISSN
2168-6149